retatrutide and glucagon vs Tirzepatide: Key Differences Explained (2026) retatrutide triple agonist gip glp-1

Titulacin gradual: Comenzar con la dosis ms baja recomendada y aumentar gradualmente segn las indicaciones de la etiqueta de la FDA reduce significativamente los efectos gastrointestinales

This leaves us with the totally reasonable question: whats the difference between Ozempic and Wegovy

[2] [4] By activating the GLP-1 receptor, retatrutide is thought to promote insulin secretion, suppress glucagon release, slow gastric emptying, and reduce appetite effects that collectively support blood glucose control and weight reduction

Assessment The single primary outcome was defined as the change of triglyceride (TG) level

Gastrointestinal side effects (nausea, vomiting, diarrhoea) affecting 2040% of patients may trigger autonomic sweating responses as a physiological stress reaction